|
May 8
|
AstraZeneca withdraws Covid-19 vaccine, citing low demand
|
|
May 8
|
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
|
|
May 8
|
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
|
|
May 8
|
AstraZeneca pulls its COVID-19 vaccine from the European market
|
|
May 8
|
AstraZeneca to withdraw Covid-19 vaccine globally
|
|
May 8
|
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
|
|
May 8
|
PRESS DIGEST-British Business - May 8
|
|
May 7
|
UPDATE 1-AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports
|
|
May 7
|
Q1 2024 FibroGen Inc Earnings Call
|
|
May 7
|
AstraZeneca concludes equity investment in Cellectis
|
|
May 6
|
Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio
|
|
May 6
|
AstraZeneca ups stake in Cellectis in latest cell therapy bet
|
|
May 6
|
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes
|
|
May 6
|
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
|
|
May 3
|
Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx
|
|
May 3
|
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
|
|
May 3
|
AstraZeneca reports positive interim data from mantle cell lymphoma trial
|
|
May 2
|
CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial
|
|
May 1
|
AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
|
|
May 1
|
AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
|